UMEIKA GRIFFITH STEPHENS: Open Payments
NPI 1851329338 · REDFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 24 payments from 9 companies in 2025. Trend: 2023 $695 · 2024 $1,514 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $253 |
| Lundbeck LLC | 7 | $238 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $155 |
| E.R. Squibb & Sons, L.L.C. | 1 | $126 |
| Alkermes, Inc. | 1 | $125 |
| COLOPLAST CORP | 1 | $71 |
| Teva Pharmaceuticals USA, Inc. | 2 | $62 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
Products named: INVEGA SUSTENNA, REXULTI, CAPLYTA, COBENFY, LYBALVI, Titan, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across MI — which companies pay providers there.
